{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:04:03Z","timestamp":1791644643358,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI160040"],"award-info":[{"award-number":["UM1 AI160040"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.anai.2021.08.014","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T04:07:56Z","timestamp":1628827676000},"page":"524-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Inhaled corticosteroids for the prevention of asthma exacerbations"],"prefix":"10.1016","volume":"127","author":[{"given":"Daniel J.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard B.","family":"Bacharier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.anai.2021.08.014_bib0001","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jamapediatrics.2021.0433","article-title":"Association of oral corticosteroid bursts with severe adverse events in children","volume":"175","author":"Yao","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2021.08.014_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamapediatrics.2017.3579","article-title":"Association between inhaled corticosteroid use and bone fracture in children with asthma","volume":"172","author":"Gray","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.anai.2021.08.014_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200807-1126OC","article-title":"Severe exacerbations and decline in lung function in asthma","volume":"179","author":"O'Byrne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.anai.2021.08.014_bib0004","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaci.2011.11.046","article-title":"Recurrent severe exacerbations in early life and reduced lung function at school age","volume":"129","author":"O'Brian","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.014_bib0005","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaip.2017.12.019","article-title":"Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma","volume":"6","author":"Ortega","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.anai.2021.08.014_bib0006","doi-asserted-by":"crossref","first-page":"149","DOI":"10.15585\/mmwr.mm6705e1","article-title":"Vital signs: asthma in children\u2014United States, 2001-2016","volume":"67","author":"Zahran","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"94","key":"10.1016\/j.anai.2021.08.014_bib0007","first-page":"1","article-title":"Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010","volume":"94","author":"Akinbami","year":"2012","journal-title":"NCHS Data Brief"},{"issue":"6989","key":"10.1016\/j.anai.2021.08.014_bib0008","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bmj.310.6989.1225","article-title":"Community study of role of viral infections in exacerbations of asthma in 9-11 year old children","volume":"310","author":"Johnston","year":"1995","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.anai.2021.08.014_bib0009","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaci.2008.08.021","article-title":"Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children","volume":"122","author":"Covar","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.014_bib0010","doi-asserted-by":"crossref","first-page":"1465-73 e5","DOI":"10.1016\/j.jaci.2014.12.1942","article-title":"Seasonal risk factors for asthma exacerbations among inner-city children","volume":"135","author":"Teach","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.anai.2021.08.014_bib0011","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.anai.2021.08.014_bib0012","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jaci.2020.01.021","article-title":"Serum IL-6: a biomarker in childhood asthma?","volume":"145","author":"Jackson","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.anai.2021.08.014_bib0013","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1164\/rccm.201909-1813OC","article-title":"Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency","volume":"202","author":"Peters","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.anai.2021.08.014_bib0014","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.1016\/j.anai.2021.08.014_bib0015","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.anai.2021.08.014_bib0016","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1164\/rccm.201103-0585OC","article-title":"Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation","volume":"184","author":"Denlinger","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.anai.2021.08.014_bib0017","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-lambda production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.anai.2021.08.014_bib0018","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.anai.2021.08.014_bib0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaci.2011.10.038","article-title":"Interferon regulatory factor 7 is a major hub connecting interferon-mediated responses in virus-induced asthma exacerbations in vivo","volume":"129","author":"Bosco","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.anai.2021.08.014_bib0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41590-019-0347-8","article-title":"Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children","volume":"20","author":"Altman","year":"2019","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.anai.2021.08.014_bib0021","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4496","article-title":"Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis","volume":"137","author":"Kaiser","year":"2016","journal-title":"Pediatrics"},{"issue":"21","key":"10.1016\/j.anai.2021.08.014_bib0022","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1056\/NEJMoa1104647","article-title":"Daily or intermittent budesonide in preschool children with recurrent wheezing","volume":"365","author":"Zeiger","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.anai.2021.08.014_bib0023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0808907","article-title":"Preemptive use of high-dose fluticasone for virus-induced wheezing in young children","volume":"360","author":"Ducharme","year":"2009","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.anai.2021.08.014_bib0024","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa042552","article-title":"Daily versus as-needed corticosteroids for mild persistent asthma","volume":"352","author":"Boushey","year":"2005","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2021.08.014_bib0025","article-title":"Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children","volume":"6","author":"Kew","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.anai.2021.08.014_bib0026","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa1710988","article-title":"Quintupling inhaled glucocorticoids to prevent childhood asthma exacerbations","volume":"378","author":"Jackson","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.anai.2021.08.014_bib0027","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJMoa1714257","article-title":"Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations","volume":"378","author":"McKeever","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.anai.2021.08.014_bib0028","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa063861","article-title":"Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma","volume":"356","author":"Papi","year":"2007","journal-title":"N Engl J Med"},{"issue":"9766","key":"10.1016\/j.anai.2021.08.014_bib0029","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.anai.2021.08.014_bib0030","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaip.2019.06.030","article-title":"A pragmatic trial of symptom-based inhaled corticosteroid use in African-American children with mild asthma","volume":"8","author":"Sumino","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.anai.2021.08.014_bib0031","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/2012.jama.10893","article-title":"Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the basalt randomized controlled trial","volume":"308","author":"Calhoun","year":"2012","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.anai.2021.08.014_bib0032","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1056\/NEJMoa1715274","article-title":"Inhaled combined budesonide-formoterol as needed in mild asthma","volume":"378","author":"O'Byrne","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.anai.2021.08.014_bib0033","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1715275","article-title":"As-needed budesonide-formoterol versus maintenance budesonide in mild asthma","volume":"378","author":"Bateman","year":"2018","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.anai.2021.08.014_bib0034","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N Engl J Med"},{"issue":"10202","key":"10.1016\/j.anai.2021.08.014_bib0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2021.08.014_bib0036","unstructured":"Global Initiative for Asthma. Global strategy for asthma management and prevention, 2020. Available at: http:\/\/www.ginasthma.org. Accessed July 1, 2021."},{"issue":"14","key":"10.1016\/j.anai.2021.08.014_bib0037","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.2018.2769","article-title":"Association of inhaled corticosteroids and long-acting beta-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis","volume":"319","author":"Sobieraj","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.anai.2021.08.014_bib0038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2466-6-13","article-title":"Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study","volume":"6","author":"Partridge","year":"2006","journal-title":"BMC Pulm Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062100572X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108112062100572X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:27:15Z","timestamp":1761053235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108112062100572X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S108112062100572X"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.014","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled corticosteroids for the prevention of asthma exacerbations","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}